<DOC>
	<DOCNO>NCT00002471</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Combining one drug may kill cancer cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat patient acute B-lymphoblastic leukemia recurrent non-Hodgkin 's lymphoma .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Acute B-Lymphoblastic Leukemia Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : I . Improve survival child adolescents poor-risk nonlymphoblastic lymphoma acute B-lymphoblastic leukemia use intensive , short-course regimen combination chemotherapy . II . Assess toxicity regimen . OUTLINE : Nonrandomized study . Induction : 7-Drug Combination Chemotherapy Leucovorin Rescue plus Triple Intrathecal Therapy ( TIT ) . Cyclophosphamide , CTX , NSC-26271 ; Thiotepa , TSPA , NSC-6396 ; Vincristine , VCR , NSC-67574 ; Daunorubicin , DNR , NSC-82151 ; Dexamethasone , DM , NSC-34521 ; Etoposide , VP-16 , NSC-141540 ; Methotrexate , MTX , NSC-740 ; Leucovorin calcium , Citrovorum Factor , CF , NSC-3590 ; plus TIT : IT MTX ; IT Cytarabine , IT ARA-C , NSC-63878 ; IT Hydrocortisone , IT HC , NSC-10483 . Consolidation : 6-Drug Combination Chemotherapy Leucovorin Rescue plus TIT . ARA-C ; VP-16 ; Asparaginase ( E. coli ) , ASP , NSC-109229 ; MTX ; VCR ; Methylprednisolone , MePRDL , NSC-19987 ; CF ; plus TIT . Reinduction : 7-Drug Combination Chemotherapy Leucovorin Rescue plus TIT . CTX ; TSPA ; VCR ; DNR ; DM ; VP-16 ; MTX ; CF ; plus TIT . PROJECTED ACCRUAL : A maximum 30 patient , accrue 4 institution , enter . If time 3 patient `` event free '' , trial terminate early , patient consider event free enter remission , die result treatment toxicity , experience progression within 1 year start therapy .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Daunorubicin</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>Thiotepa</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose undifferentiated nonlymphoblastic nonHodgkin 's lymphoma ( Burkitt 's nonBurkitt 's ) Newly diagnose large cell lymphoma CNS involvement Recurrent nonHodgkin 's lymphoma L3 Bcell leukemia include At least 1 follow require : LDH least 500 IU/liter ( old method ) 2,000 IU/liter ( new method ) Bone marrow involvement ( great 5 % lymphoblast ) CNS involvement ( lymphoblasts CSF cytospin intracranial mass CT MRI scan ) PATIENT CHARACTERISTICS : Age : Any age Performance status : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Prior therapy allow nonHodgkin 's lymphoma No prior therapy disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>childhood Burkitt lymphoma</keyword>
	<keyword>L3 childhood acute lymphoblastic leukemia</keyword>
	<keyword>B-cell childhood acute lymphoblastic leukemia</keyword>
	<keyword>L3 adult acute lymphoblastic leukemia</keyword>
	<keyword>B-cell adult acute lymphoblastic leukemia</keyword>
	<keyword>recurrent adult non-Hodgkin lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>stage III childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage IV childhood small noncleaved cell lymphoma</keyword>
	<keyword>stage IV childhood large cell lymphoma</keyword>
	<keyword>recurrent childhood small noncleaved cell lymphoma</keyword>
	<keyword>recurrent childhood large cell lymphoma</keyword>
</DOC>